Are insiders buying Aytu BioPharma stock?

In the last 12 months, insiders at Aytu BioPharma bought $0 of stock and sold $0 across 8 Form 4 filings.

Who bought Aytu BioPharma stock recently?

The most recent insider purchase at Aytu BioPharma was by Joshua R. Disbrow (CEO), reported on June 10, 2025, with a transaction value of $99,999.

No insiders reported selling Aytu BioPharma shares in the last 12 months.

Officer, director, and 10%+ owner transactions reported to the SEC on Form 4, with buy/sell totals and cluster activity for Aytu BioPharma.

Bought (12 mo) $0

Sold (12 mo) $0

Insiders Buying (12 mo) 0

Insiders Selling (12 mo) 0

Form 4 Filings (All Time) 71

Most Recent Purchase

June 10, 2025

Joshua R. Disbrow CEO

$99,999

Buys (90d) 0

Sells (90d) 0

Recent Insider Transactions

Recent insider transactions
Filed	Insider	Role	Type	Value	% Change